- HK$5.20bn
- HK$5.94bn
- HK$2.00bn
- 51
- 16
- 80
- 47
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 147 | 340 | 687 | 1,443 | 2,001 |
Cost of Revenue | |||||
Gross Profit | 105 | 166 | 349 | 591 | 850 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 205 | 223 | 681 | 1,257 | 1,862 |
Operating Profit | -58.2 | 117 | 5.41 | 185 | 139 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -63.3 | 67.1 | -14.9 | 92.5 | 47.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -48.7 | 81.2 | -22.7 | 58.1 | -0.21 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -48.7 | 81.2 | -22.7 | 42 | -7.82 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -48.7 | 81.2 | -22.7 | 42 | -7.82 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.029 | 0.044 | -0.012 | 0.018 | -0.002 |